We understand that what matters most is you. Whether you’re an individual affected by rare disease, caregiver, doctor, or business partner, you drive us to build a better world. A world in which everyone can find the treatment and care we need. That’s why, after 85 years of experience, Chiesi Group launched Chiesi Global Rare Diseases in 2020.
People are at the heart of everything we do
The people at Chiesi Global Rare Diseases are motivated by a shared personal drive to help patients with rare diseases. We recognize that commitment… Read More
Leading with purpose
Meet the team committed to creating a difference in the lives of individuals impacted by rare diseases. Read More
We are one big global family
As a part of the Chiesi Group, growing and supporting diversity and ensuring equal opportunity and equal pay for equal work are priorities at Chiesi Global Rare Diseases... Read More
Like our patients, we believe our planet is one of a kind
Chiesi is the largest global pharmaceutical group to be awarded B Corp Certification, a recognition... Read More
Over the years
“We honor rare disease patients' struggle, and we want to make sure that we are as courageous as they are in fighting their diseases as we go out and try and make a difference in their lives.”
Giacomo Chiesi
Head of Global Rare Diseases
International Research Centers
Europe and North America
Manufacturing Plants
Europe and Latin America
Countries
With Chiesi Group Operations
Learn More about Chiesi Global Rare Diseases
Find
Treatments
Discover innovative treatments that are helping to change the rare disease landscape.
See
Products
Discover treatments that are helping to change the rare disease landscape.
See
Pipeline
Explore novel therapies being developed and approved across different indications.
See
Pipeline
Explore rare disease therapies under development.
Be
a Partner
From understanding rare diseases to providing new products—together, we can do more.
Join
the Family
Interested in a career at Chiesi Global Rare Diseases? We’d love to hear from you.